常見(jiàn)例句Conclusion The plasminogen ability is lower in women with PCOS. 結(jié)論P(yáng)COS患者的血纖溶能力較正常對(duì)照者有所下降。We studied the mechanism of plasmaand tissue kallikreinin activating plasminogen. 作者研究了血漿和組織激肽釋放酶激活纖溶酶原的機(jī)制。THE EXPRESSION OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR IN ORAL SQUAMOUS CELL CARCINOMA. 尿激酶受躰在口腔鱗癌中的表達(dá)。Recombinant tissue-type plasminogen activator (r-TPA) was also used when clinically indicated. 臨牀上有指征時(shí)也可應(yīng)用重組組織型纖溶酶原激活劑。In this process, urokinase-type plasminogen activator(uPA) and P-selectin play a very important role . 在此過(guò)程中,尿激酶型纖溶酶原激活物(urokinase-type plasminogen activator,uPA)和P-選擇素起著十分重要的作用。PURPOSE:To establish a stable cell strain secreted recombinant tissue-type plasminogen activator(rt-PA). 目的:建立穩(wěn)定表達(dá)人組織型纖溶酶原激活劑(tissue-type plasminogen activatort-PA)的細(xì)胞系。 返回 plasminogen